2.5mg/ml semaglutide and tirzepatide injections for weight loss Ozempic® (semaglutide) injection 0.5mg, 1

Source: Gorgojo et al, published in the journal, Journal of Clinical Medicine in 2023

2014 Phase II trial (117 bowel surgery patients, NCT00672074), ipamorelin given as 0.03 mg/kg IV twice daily for up to 7 days produced treatment-related adverse event rates similar to placebo

Check Your Eligibility Free Consultation (Prospective Patients) Starting July 1, 2026 , Medicare Part D covers Wegovy, Zepbound, and Foundayo for weight loss through the new GLP-1 Bridge program

Doctors will treat the individual symptoms youre experiencing

the most abundant carnitine ester) are around 3 to 6 mol/L (8)

Clinical Benefits Protects and heals the gastrointestinal tract, supporting gut lining integrity and helping address inflammatory bowel conditions and digestive issues